Join the Virtual Networking Room, hosted by @Merck, for an interactive networking session focused on biomarker access, collaboration, and the future of precision oncology. June 18 | 11:45 AM - 12:15 PM ET #BiomarkerTesting #ComprehensiveGenomicProfiling #CGP #PrecisionOncology

For your patients with HCC, #ComprehensiveGenomicProfiling can provide actionable genomic insights for confident, real-time treatment decisions in therapy selection. See how the #PanTracer portfolio can support your #LiverCancer management: neogenomics.com/providers/on…

📰 Omico’s May newsletter is out now. Want to keep up with our work to advance precision oncology? Our newsletter brings you regular updates on Omico’s national initiatives, events, collaborations and progress — all aimed at improving access to precision oncology in Australia. 📖 Read it online: zcu.nz/RXuG?m=0 📩 Subscribe to get the next issue: omico.com.au/webform/ #CancerMeetsItsMatch #CGP #ComprehensiveGenomicProfiling #ClinicalTrialMatching #TreatmentMatching

While #InternationalClinicalTrialsDay has just passed, the importance of clinical trials — and the partnerships that make them possible — is front of mind every day at Omico. We’d like to take a moment to thank @merckgroup for their partnership, commitment and energy in helping improve treatment options for people with cancer. Merck is a valued collaborator in our mission to expand access to precision oncology and clinical trials — and we’re proud to work alongside a company so deeply invested in advancing science and improving outcomes. We share a common goal: ensuring that more Australians, wherever they live, can benefit from the latest innovations in cancer care. Thank you to Merck — and to every partner, patient and clinician helping to move cancer care forward. #CancerMeetsItsMatch #PrecisionOncology #ComprehensiveGenomicProfiling #ClinicalTrials #TreatmentMatching #Partnerships

📺 Tonight on ABC’s #AustralianStory 📺 Join Samuel Johnson and #LoveYourSister Foundation on their extraordinary mission to change cancer care across the country — care that’s precise, personal, and powered by community. Omico's @ProfDMThomas also makes an appearance, reflecting on the valued Omico/Love Your Sister partnership and the shared goal of giving more people access to personalised, life-changing treatments. 🕢 8:00pm on ABC TV and #ABCiview #LoveYourSister #CancerMeetsItsMatch #PrecisionOncology #PrecisionCancerMedicine #ComprehensiveGenomicProfiling #ClinicalTrialMatching #TreatmentMatching #LeaveNooneBehind @abcnews @UNSWMedicine @cancerNSW

Who is eligible for comprehensive genomic profiling (CGP) through Omico’s Cancer Screening Program (CaSP)? In this short clip from our Cancer & Genomics webinar, A/Prof. Mandy Ballinger explains that free CGP and clinical trial matching is available for Australians with advanced, incurable, or poor prognosis cancers. ▶️ Watch the full webinar on demand to learn more about accessing CGP and how it may help guide your treatment options: lnkd.in/gqRXeJ9n 📘 Download our patient booklet for more details: bit.ly/3XHYdTk #CancerMeetsItsMatch #ComprehensiveGenomicProfiling #TreatmentMatching #ClinicalTrialMatching #KnowYourOptions #BeYourOwnAdvocate

Meet Omico’s National Clinical Trials Network (ONCTN) Clinical trials play a vital role in bringing innovative, precision therapies to people with hard-to-treat cancers – offering access to new treatment options and hope. Omico’s ONCTN team exists to make these opportunities more available and accessible across Australia. By attracting more biomarker-led and international trials to our shores, ONCTN is helping position Australia as a global hub for precision oncology research. Our national network now includes over 69 sites – up from 34 just two years ago – with 22 located in regional areas, helping to ensure more patients and clinicians can participate, no matter where they live. In the past 2 years alone, Omico has supported 72 industry-sponsored trials via this network, 16 of which would not have reached Australia without our molecular profiling infrastructure. Want to learn more or get involved? Contact us here: sites@omico.org.au #CancerMeetsItsMatch #CGP #ComprehensiveGenomicProfiling #ClinicalTrialMatching #TreatmentMatching #ONCTN #KnowYourOptions

Real progress, real hope. What once felt like science fiction is now saving lives. As @ProfDMThomas shares, genomics is already changing cancer care — and the science is only getting stronger. 📽️ Watch this short clip for a dose of realistic optimism about where cancer care is headed, and 🎧 tune into the full episode here: Our website: lnkd.in/g4b_4UBG Apple Podcasts: lnkd.in/gSYAsaZV Spotify: lnkd.in/gjyqEZwA iHeart: lnkd.in/g8HpAHdg Amazon: lnkd.in/gSVpcc4m #CancerMeetsItsMatch #PrecisionOncology #ComprehensiveGenomicProfiling #ClinicalTrialMatching #TreatmentMatching #KnowYourOptions

The future is bright — and it’s already underway. 📷 Episode 8: "Future Prospects – What Lies Ahead?" wraps up the series — and you won’t want to miss it. In the final episode of the #CancerMeetsItsMatch podcast, we look ahead to what’s next in cancer care — and why there’s reason for real hope. 📷 Out now, for sharing and tuning in: Our website: lnkd.in/g4b_4UBG Apple Podcasts: lnkd.in/gSYAsaZV Spotify: lnkd.in/gjyqEZwA iHeart: lnkd.in/g8HpAHdg Amazon: lnkd.in/gSVpcc4m #CancerMeetsItsMatch #PrecisionOncology #ComprehensiveGenomicProfiling #ClinicalTrialMatching #TreatmentMatching #KnowYourOptions @ProfDMThomas @RareCancers @CancerAustralia @cancerNSW

Tara’s dad was diagnosed with renal cell carcinoma, and treatment options were limited — until his oncologist recommended Omico’s Cancer Screening Program (CaSP). 📽️ Watch this short clip to learn how treatment-matching gave Tara’s family new direction — and 🎧 catch the full episode here: Our website: lnkd.in/g4b_4UBG Apple Podcasts: lnkd.in/gSYAsaZV Spotify: lnkd.in/gjyqEZwA iHeart: lnkd.in/g8HpAHdg Amazon: lnkd.in/gSVpcc4m #CancerMeetsItsMatch #PrecisionOncology #ComprehensiveGenomicProfiling #ClinicalTrialMatching #TreatmentMatching #KnowYourOptions

🎙️NEW - Episode 5 in our “Cancer Meets its Match” podcast is out today. In this episode, Dr Dr Ginni Mansberg GAICD discusses “Inside A Modern-Day Clinical Trial – Experiences & Insights” with A/Prof. James Lyneham (Director, Medical Oncology, Calvary Mater Newcastle) and Dr Niara Oliveira (Senior Medical Oncologist, Mater Hospital Brisbane). 🎧 Listen now—new episodes weekly. Our website: lnkd.in/g4b_4UBG Apple Podcasts: lnkd.in/gSYAsaZV Spotify: lnkd.in/gjyqEZwA iHeart: lnkd.in/g8HpAHdg Amazon: lnkd.in/gSVpcc4m #CancerMeetsItsMatch #PrecisionOncology #ComprehensiveGenomicProfiling #ClinicalTrialMatching #TreatmentMatching #KnowYourOptions @RareCancers @CancerAustralia @cancerNSW

🚗🧬 Cars and fingerprints—how do they relate to cancer treatment? A/Prof. Zielinski explains: “We’re really demanding more knowledge about our cancer—and that’s where precision oncology comes in.” 🎧 Watch this clip to hear his take, then catch the full episode on: Our website: lnkd.in/g4b_4UBG Apple Podcasts: lnkd.in/gSYAsaZV Spotify: lnkd.in/gjyqEZwA iHeart: lnkd.in/g8HpAHdg Amazon: lnkd.in/gSVpcc4m #CancerMeetsItsMatch #PrecisionOncology #ComprehensiveGenomicProfiling #ClinicalTrialMatching #TreatmentMatching #KnowYourOptions

Episode 4 of "Cancer Meets Its Match" is now available! 🎙️Finding Your Match Through CGP with A/Prof. Rob Zielinski (Orange Base Hospital, Western Sydney University). In this episode, A/Prof. Rob Zielinski explains how CGP guides treatment decisions and helps more Australians access precision oncology—wherever they live. While it’s easy to assume services like these are only available in major cities, that’s not the case. Rob is one of many oncologists in regional Australia ensuring patients outside metro centres can also benefit from Omico’s programs. 🎧 Tune in now! Our website: lnkd.in/g4b_4UBG Apple Podcasts: lnkd.in/gSYAsaZV Spotify: lnkd.in/gjyqEZwA iHeart: lnkd.in/g8HpAHdg Amazon: lnkd.in/gSVpcc4m #CancerMeetsItsMatch #PrecisionOncology #ComprehensiveGenomicProfiling #ClinicalTrialMatching #TreatmentMatching #KnowYourOptions @RareCancers @CancerAustralia @cancerNSW

Episode 2 'Inside Omico’s Cancer Screening Program (CaSP)' of our "Cancer Meets Its Match" podcast series is out now! This episode dives into what the Comprehensive Genomic Profiling (CGP) process involves and what to expect featuring Assoc. Prof. Mandy Ballinger (Omico, UNSW) & Laura Manual (Omico, UNSW). 📷 Listen now on: Our website: lnkd.in/g4b_4UBG Apple Podcasts: lnkd.in/gSYAsaZV Spotify: lnkd.in/gjyqEZwA iHeart: lnkd.in/g8HpAHdg Amazon: lnkd.in/gSVpcc4m #CancerMeetsItsMatch #PrecisionOncology #ComprehensiveGenomicProfiling #ClinicalTrialMatching #TreatmentMatching #KnowYourOptions @RareCancers @CancerAustralia @cancerNSW

Omico’s mission to mainstream precision oncology. With our 2025-26 Pre-Budget Submission, Omico is advocating for our PrO-HSI initiative, a transformative approach to delivering cutting-edge precision oncology to Australians, starting with those who need it most – those with rare cancers. PrO-HSI, short for Precision Oncology Health System Incubator, is about creating a future where the best science in cancer care is mainstream, sustainable, and accessible — not reliant on fleeting grants, but built to last for generations. It’s about transforming the landscape to deliver affordable access to state-of-the-art healthcare, simultaneously driving economic growth and reducing out-of-pocket costs for patients. It also aligns with key initiatives, addressing 24 of the 50 recommendations from the HTA Policy and Methods Review and 18 of the 41 recommendations from the 2024 Senate Inquiry into rare cancers. Join us in supporting our PrO-HSI proposal to transform cancer care. Want more detail? Read our Pre-Budget Submission here: lnkd.in/gg9ysC27 Read our media release here: lnkd.in/ghZEkHC3 @RareCancers @CancerAustralia @cancerNSW #CancerMeetsItsMatch #CGP #ComprehensiveGenomicProfiling #ClinicalTrialMatching #TreatmentMatching

Omico and @RareCancers: A Partnership for Progress in Precision Oncology. Our long-standing partnership with RCA is built on a shared commitment to advancing precision oncology and improving awareness and access to CGP, matching to precision treatments and clinical trials. Our recent meeting combined thoughtful planning with lighter moments—proof that meaningful collaboration can be both impactful and enjoyable! Together, we’re dedicated to making a real difference for patients facing rare, complex, and advanced cancers. What a fantastic way to kick off 2025! @ProfDMThomas @kymbramich #ComprehensiveGenomicProfiling #PrecisionOncology #PatientAdvocacy

Dr. Ginni Mansberg, a highly regarded television doctor, recently featured Omico and our innovative precision oncology initiatives in her segment on @Channel7's @sunriseon7! By shining a spotlight on Omico's work, Dr. Mansberg helped educate the Australian public about the the transformative potential of genomic medicine, highlighting how it can improve experiences and results for people living with difficult-to-treat cancers. We're very grateful to Ginny for this mention. If case you missed it, you can view the 1 minute segment via the link below. #Omico #PrecisionOncology #CancerMeetsItsMatch #ComprehensiveGenomicProfiling #Sunrise #DrGinnyMansfield

When Beth was working as an oncology nurse, she was diagnosed with advanced bile duct cancer. Faced with a devastating diagnosis, Beth pursued comprehensive genomic profiling (CGP) to understand more about her cancer and was subsequently matched to a clinical trial with an innovative treatment matched to her specific cancer. If you are living with an advanced or incurable cancer, or have an earlier diagnosis of a poor prognosis cancer, you may be eligible for free CGP through Omico. To see if your eligible, simply download the patient information booklet to have as a handy resource when you speak to your cancer doctor (oncologist): bit.ly/3XHYdTk Or to hear from brave individuals like Beth who experienced it firsthand, visit: omico.com.au/patients-and-fa… #Omico #PrecisionOncology #CancerMeetsItsMatch #ComprehensiveGenomicProfiling #MeetThePatientsThatMatched

Flabbergasted!!... Omico has been honoured with the NGO of the Year award at the #PRIMEAwards last night! Thank you PRIME Awards for the recognition and for hosting such a wonderful evening! Our congratulations to all the outstanding NGO finalists — @RareCancers , #LiverFoundation, #ArterialEducation #HeadandNeckCancerAustralia — we’re honoured to stand alongside you in driving meaningful change. To learn more about our mission and how we’re driving change in precision oncology, visit our website: omico.com.au/ #Omico #PrecisionOncology #CancerMeetsItsMatch #ComprehensiveGenomicProfiling #PrimeAwards #NGOoftheyear @ProfDMThomas

🌟 Omico’s very own @ProfDMThomas, is now a finalist for the 2024 French-Australian Excellence Awards in the Health & Wellbeing category! 🗳️ Ready to vote? Just click here: lcanews.com/french-australia… Scroll to the Health & Wellbeing section to cast your vote for David. 🗓️ Don’t wait—voting closes on 15 November! Join us in shining a light on David’s inspiring work and amplifying Omico’s mission to make precision oncology accessible to all Australians. #Omico #PrecisionOncology #CancerMeetsItsMatch #ComprehensiveGenomicProfiling